Functional neurochemical evidence for the presence of presynaptic nicotinic acetylcholine receptors at the terminal region of myenteric motoneurons: A study with epibatidine

Neurochemical Research

Volumn 28, Issue 3-4, 2003, Pages 407-412

  Mandl, P ^a   Kiss, J P ^a   Vizi, E S ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Epibatidine; Longitudinal muscle strip; Myenteric plexus; Presynaptic nicotinic acetylcholine receptors

Indexed keywords

ACETYLCHOLINE; ATROPINE; EPIBATIDINE; MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; SODIUM CHANNEL BLOCKING AGENT; TRITIUM;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; GUINEA PIG; MALE; MOTONEURON; MUSCLE ISOMETRIC CONTRACTION; MUSCLE TISSUE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; ISOMETRIC CONTRACTION; MALE; MOTOR NEURONS; MUSCLE, SKELETAL; MYENTERIC PLEXUS; NICOTINE; NICOTINIC AGONISTS; OSMOLAR CONCENTRATION; PRESYNAPTIC TERMINALS; PYRIDINES; RECEPTORS, NICOTINIC;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0037375787     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022884231313     Document Type: Article

References (31)

1. Torocsik, A., Oberfrank, F., Sershen, H., Lajtha, A., Nemesy, K., and Vizi, E. S. 1991. Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur. J. Pharmacol. 202:297-302.
2. Vizi, E. S., Sershen, H., Balla, A., Mike, A., Windisch, K., Juranyi, Z., and Lajtha, A. 1995. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors. Ann. N. Y. Acad. Sci. 757:84-99.
3. Galligan, J. J. 1999. Nerve terminal nicotinic cholinergic receptors on excitatory motoneurons in the myenteric plexus of guinea pig intestine. J. Pharmacol. Exp. Ther. 291:92-98.
4. Ehlert, F. J., Sawyer, G. W., and Esqueda, E. E. 1999. Contractile role of M2 and M3 muscarinic receptors in gastrointestinal smooth muscle. Life Sci. 64:387-394.
5. Vizi, E. S. 1979. Presynaptic modulation of neurochemical transmission. Prog. Neurobiol. 12:181-290.
6. Paton, W. D. and Vizi, E. S. 1969. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea pig ileum longitudinal muscle strip. Br. J. Pharmacol. 35:10-28.
7. Paton, W. D., Vizi, E. S., and Zar, M. A. 1971. The mechanism of acetylcholine release from parasympathetic nerves. J. Physiol. 215:819-848.
8. Schneider, D. A., Perrone, M., and Galligan, J. J. 2000. Nicotinic acetylcholine receptors at sites of neurotransmitter release to the guinea pig intestinal circular muscle. J. Pharmacol. Exp. Ther. 294:363-369.
9. Niebler, M. and Trendelenburg, U. 1990. Mechanisms of the release of 3H-noradrenaline by dimethylphenylpiperazinium (DMPP) in the rat vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 341:43-49.
10. Kiss, J. P., Windisch, K., Balla, A., Sershen, H., and Lajtha, A. 1997. Dual effect of DMPP on the resting release of noradrenaline from rat hippocampal slices. Brain Res. Bull. 43: 257-262.
11. Kiss, J. P., Windisch, K., De Oliveira, K., Hennings, E. C., Mike, A., and Szasz, B. K. 2001. Differential effect of nicotinic agonists on the [3H]norepinephrine release from rat hippocampal slices. Neurochem. Res. 26:943-950.
12. Arqueros, L., Naquira, D., and Zunino, E. 1978. Nicotine-induced release of catecholamines from rat hippocampus and striatum. Biochem. Pharmacol. 27:2667-2674.
13. Bonhaus, D. W., Bley, K. R., Broka, C. A., Fontana, D. J., Leung, E., Lewis, R., Shieh, A., and Wong, E. H. 1995. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J. Pharmacol. Exp. Ther. 272: 1199-1203.
14. Gerzanich, V., Peng, X., Wang, F., Wells, G., Anand, R., Fletcher, S., and Lindstrom, J. 1995, Comparative pharmacology of epibatidine: A potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48:774-782.
15. Lembeck, F. 1999. Epibatidine: High potency and broad spectrum activity on neuronal and neuromuscular nicotinic acetylcholine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 359:378-385.
16. Kirchgessner, A. L. and Liu, M. T. 1998. Immunohistochemical localization of nicotinic acetylcholine receptors in the guinea pig bowel and pancreas. J. Comp. Neurol. 390:497-514.
17. Spande, T. F., Garraffo, H. M., Yeh, H. J., Pu, Q. L., Pannell, L. K., and Daly, J. W. 1992. A new class of alkaloids from a dendrobatid poison frog: A structure for alkaloid 251F. J. Nat. Prod. 55:707-722.
18. Bannon, A. W., Decker, M. W., Holladay, M. W., Curzon, P., Donnelly-Roberts, D., Puttfarcken, P. S., Bitner, R. S., Diaz, A., Dickenson, A. H., Porsolt, R. D., Williams, M., and Arneric, S. P. 1998. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 279:77-81.
19. Donnelly-Roberts, D. L., Puttfarcken, P. S., Kuntzweiler, T. A., Briggs, C. A., Anderson, D. J., Campbell, J. E., Piattoni-Kaplan, M., McKenna, D. G., Wasicak, J. T., Holladay, M. W., Williams, M., and Arneric, S. P. 1998. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: A novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. J. Pharmacol., Exp. Ther. 285:777-786.
20. Qian, C., Li, T., Shen, T. Y., Libertine-Garahan, L., Eckman, J., Biftu, T., and Ip, S. 1993. Epibatidine is a nicotinic analgesic. Eur. J. Pharmacol. 250:R13-R14.
21. Alkondon, M. and Albuquerque, E. X. 1995. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J. Pharmacol. Exp. Ther. 274:771-782.
22. Kadlec, O., Seferna, I., Sevcik, J., Somogyi, G. T., and Vizi, E. S. 1990. The topographical basis of cholinergic transmission in guinea pig ileum myenteric plexus. Neuroscience 36:793-802.
23. Somogyi, G. T. and Vizi, E. S. 1988. Evidence that cholinergic axon terminals are equipped with both muscarinic and adenosine receptors. Brain Res. Bull. 21:575-579.
24. Wonnacott, S. 1997. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:92-98.
25. Vizi, E. S. and Lendvai, B. 1999. Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res. Brain Res. Rev. 30:219-235.
26. Vizi, E. S. 2000. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Pharmacol. Rev. 52:63-90.
27. Coulie, B., Camilleri, M., Bharucha, A. E., Sandborn, W. J., and Burton, D. 2001. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol. Ther. 15: 653-663.
28. Green, J. T., McKirdy, H. C., Rhodes, J., Thomas, G. A., and Evans, B. K. 1999. Intra-luminal nicotine reduces smooth muscle tone and contractile activity in the distal large bowel. Eur. J. Gastroenterol. Hepatol. 11:1299-1304.
29. Meier, R., Beglinger, C., Dederding, J. P., Meyer-Wyss, B., Fumagalli, M., Rowedder, A., Turberg, Y., and Brignoli, R. 1995. Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol. Motil. 7:235-238.
30. Rausch, T., Beglinger, C., Alam, N., Gyr, K., and Meier, R. 1998. Effect of transdermal application of nicotine on colonic transit in healthy nonsmoking volunteers. Neurogastroenterol. Motil. 10:263-270.
31. Somogyi, G. T., Zernova G. V., Yoshiyama, M., Rocha, J. N., Smith C. P., and Groat, W. C. 2003. Change in muscarinic modulation of transmitter release in the rat urinary bladder after spinal cord injury. Neurochem. Int. In press.